Related Experiment Video
Updated: Jul 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDMX regulation of p53 response to ribosomal stress
Daniele M Gilkes1, Lihong Chen, Jiandong Chen
1Molecular Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Abstract:
Ribosomal stress such as disruption of rRNA biogenesis activates p53 by release of ribosomal proteins from the nucleoli, which bind to MDM2 and inhibit p53 degradation. We found that p53 activation by ribosomal stress requires degradation of MDMX in an MDM2-dependent fashion. Tumor cells overexpressing MDMX are less sensitive to actinomycin D-induced growth arrest due to formation of inactive p53-MDMX complexes. Knockdown of MDMX increases sensitivity to actinomycin D, whereas MDMX overexpression abrogates p53 activation and prevents growth arrest. Furthermore, MDMX expression promotes resistance to the chemotherapeutic agent 5-fluorouracil (5-FU), which at low concentrations activates p53 by inducing ribosomal stress without significant DNA damage signaling. Knockdown of MDMX abrogates HCT116 tumor xenograft formation in nude mice. MDMX overexpression does not accelerate tumor growth but increases resistance to 5-FU treatment in vivo. Therefore, MDMX is an important regulator of p53 response to ribosomal stress and RNA-targeting chemotherapy agents.
Insights
MDMX degradation is crucial for p53 activation during ribosomal stress. This protein promotes resistance to chemotherapy, making it a potential target for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Ribosomal stress activates the tumor suppressor p53.
- MDM2 inhibits p53 degradation, while MDMX can form inactive complexes with p53.
- The role of MDMX in p53 activation during ribosomal stress is not fully understood.
Purpose of the Study:
- To investigate the role of MDMX in p53 activation induced by ribosomal stress.
- To determine if MDMX affects sensitivity to RNA-targeting chemotherapy agents.
Main Methods:
- Studied p53 activation in response to ribosomal stress and chemotherapy.
- Utilized MDMX knockdown and overexpression cell models.
- Assessed tumor xenograft formation and response to 5-fluorouracil in vivo.
Main Results:
- p53 activation by ribosomal stress requires MDMX degradation in an MDM2-dependent manner.
- MDMX overexpression confers resistance to actinomycin D and 5-fluorouracil (5-FU).
- MDMX knockdown enhances sensitivity to these chemotherapeutic agents and abrogates tumor xenograft formation.
Conclusions:
- MDMX is a key regulator of the p53 response to ribosomal stress.
- MDMX promotes resistance to RNA-targeting chemotherapy agents like 5-FU.
- Targeting MDMX may enhance the efficacy of chemotherapy in cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Regulation of the Unfolded Protein Response
Stringent Response in E. coli
Negative Regulator Molecules

